(Left to Right) Dr. Michael Markowitz (UCB), Dr. Shruti Raja, and Dr. Robert Dupuis (UNC Eshelman School of Pharmacy)
An important part of the drug development continuum is ensuring trained specialists are engaged through discovery, development, and delivery. Neurotherapeutics, or treatment of disorders of the nervous system, is a research area with a limited number of highly trained neurologists working in drug development. To help fill this gap, the UCB-UNC-Duke Neurology Clinical Development Fellowship program was developed for board certified neurologists seeking further training in neurology drug development.